Ipatasertib Completed Phase 1 Trials for Healthy Volunteers Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT03222310A Study to Evaluate the Effect of a Potent Cytochrome P450 (CYP) 3A Inhibitor on Ipatasertib
NCT02063581A Study Evaluating the Effect of Formulation on the Bioavailability of Ipatasertib in Healthy Volunteers